Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO6799477 multiple-dose safety, PK/PD study in healthy volunteers and type 2 diabetes patients
NL-OMON40841Active, not recruiting
- Sponsor
- Roche
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of RO6799477 in affective disorder, schizophrenia and type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Jun 2014; status: active, not recruiting.
02
Drugs
RO6799477
03
Conditions
affective disorderschizophreniatype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON40841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40841.